Literature DB >> 10567117

Screening for ovarian cancer. We now need a definitive randomised trial.

N Urban.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10567117      PMCID： PMC1117062          DOI： 10.1136/bmj.319.7221.1317

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Quantifying the potential benefit of CA 125 screening for ovarian cancer.

Authors:  S J Skates; D E Singer
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

2.  Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening.

Authors:  N Urban; C Drescher; R Etzioni; C Colby
Journal:  Control Clin Trials       Date:  1997-06

Review 3.  The status of ultrasound and color Doppler imaging for the early detection of ovarian carcinoma.

Authors:  B Y Karlan
Journal:  Cancer Invest       Date:  1997       Impact factor: 2.176

Review 4.  Transvaginal sonography as a screening method for the detection of early ovarian cancer.

Authors:  P D DePriest; H H Gallion; E J Pavlik; R J Kryscio; J R van Nagell
Journal:  Gynecol Oncol       Date:  1997-06       Impact factor: 5.482

5.  Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.

Authors:  B Y Karlan; R L Baldwin; E Lopez-Luevanos; L J Raffel; D Barbuto; S Narod; L D Platt
Journal:  Am J Obstet Gynecol       Date:  1999-04       Impact factor: 8.661

6.  Screening for ovarian cancer: a pilot randomised controlled trial.

Authors:  I J Jacobs; S J Skates; N MacDonald; U Menon; A N Rosenthal; A P Davies; R Woolas; A R Jeyarajah; K Sibley; D G Lowe; D H Oram
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

7.  Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Authors:  I Jacobs; A P Davies; J Bridges; I Stabile; T Fay; A Lower; J G Grudzinskas; D Oram
Journal:  BMJ       Date:  1993-04-17

8.  Variability in radiologists' interpretations of mammograms.

Authors:  J G Elmore; C K Wells; C H Lee; D H Howard; A R Feinstein
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

9.  Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

Authors:  S J Skates; F J Xu; Y H Yu; K Sjövall; N Einhorn; Y Chang; R C Bast; R C Knapp
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

Review 10.  The CA 125 tumour-associated antigen: a review of the literature.

Authors:  I Jacobs; R C Bast
Journal:  Hum Reprod       Date:  1989-01       Impact factor: 6.918
View more
  2 in total

1.  Making decisions about screening for ovarian cancer. Who chooses when an operation is worth having?

Authors:  A Barratt
Journal:  BMJ       Date:  2000-04-01

Review 2.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.